In a 12-month retrospective study of 339 Second Nature members published in JMIR Formative Research, participants on tirzepatide lost an average of 22.1% of their body weight, and those on semaglutide lost 17.1% 5
These drugs are making headlines for their ability to lower blood sugar and support weight loss but what are they and how do they work
The GLP-1 drug participants had no progression of motor symptoms (-0.04), and the 3.04 worsening in the placebo group (difference between the two arms=3.08) is just short of what is considered clinically meaningful (3.5)
- ClinicalTrials.gov
Faster dose increases led to higher rates of nausea (up to 60% versus 44% with standard titration), more vomiting, and significantly higher protocol discontinuation rates
The seven peptides on the Section 503A Bulk Drug Substances List agenda split across the two meeting days: Day 1 (July 23): BPC-157 (ulcerative colitis), KPV (wound healing and inflammatory conditions), TB-500 (wound healing), MOTS-c (obesity and osteoporosis)
